title: Evidence Brief — Demo Study in Hypertension
indication: Hypertension
population: Adults 40–80 years with stage 1–2 hypertension
intervention: Drug X (once daily)
comparator: Placebo
endpoints:
  - Primary
  - Secondary
safety_notes: "No serious safety signals in this simulated dataset; mild adverse events comparable across arms."
key_messages:
  - Drug X shows improved outcomes over placebo in the simulated cohort.
  - Effect magnitude should be confirmed in real-world or clinical trial data.
limitations:
  - Synthetic data; not inferential.
  - Simplified model; no time-to-event analysis.
created_by: Maria Camila Cuesta
version: 1.0
